<DOC>
	<DOCNO>NCT02220517</DOCNO>
	<brief_summary>The hypothesis study target MRI/US fusion-guided prostate biopsy additional systematic transrectal ultrasound ( TRUS ) -guided biopsy significantly detect prostate cancer target MR-guided in-bore prostate .</brief_summary>
	<brief_title>Randomized Study Comparing MR-guided Bore Versus MRI/US Fusion-guided Prostate Biopsy</brief_title>
	<detailed_description>In men previously negative prostate biopsy persistent elevate prostate-specific antigen ( PSA ) value , unclear strategy offer high detection rate prostate cancer . The hypothesis study target MRI-guided biopsy combine transrectal ultrasound ( TRUS ) -guided biopsy may potentially detect cancer MRI-guided prostate biopsy alone . Men least one previously negative TRUS-guided biopsy persistently elevate PSA value submit multiparametric MRI examination prostate . Subsequently , participant randomize ( 1:1 ) study arm . In study arm A patient submit targeted prostate biopsy base multiparametric MRI finding . Targeted biopsy perform use MRI-guided in-bore prostate biopsy . In study arm B target biopsy perform use MRI/TRUS-fusion-guided prostate biopsy software-registration ( MRI/TRUS image fusion ) . Patients study arm B undergo additional systematic 12-core TRUS-guided prostate biopsy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>At least one prior negative prostate biopsy Prostatespecific antigen ( PSA ) &gt; 4 ng/ml Known prostate cancer Contraindications MRI Contraindications prostate biopsy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>MRI/US fusion-guided prostate biopsy</keyword>
	<keyword>MR-guided in-bore prostate biopsy</keyword>
	<keyword>prostate cancer</keyword>
</DOC>